Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy

Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy

Growth failure is a common problem in HIV-infected children. The extent to which this growth failure could be reversed after the children receive antiretroviral therapy (ART) is not known. This study assessed the incidence of growth failure in HIV-infected Thai children, impact of ART on growth, and...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Linda Aurpibul, Thanyawee Puthanakit, Sineenart Taecharoenkul, Thira Sirisanthana, Virat Sirisanthana
التنسيق:	دورية
منشور في:	2018
الموضوعات:	Medicine
الوصول للمادة أونلاين:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77149172823&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/49263
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
بواسطة: Linda Aurpibul, وآخرون
منشور في: (2018)

Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
بواسطة: Aurpibul L., وآخرون
منشور في: (2014)

Recovery from lipodystrophy in HIV-infected children after substitution of stavudine with zidovudine in a non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
بواسطة: Linda Aurpibul, وآخرون
منشور في: (2018)

Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
بواسطة: Linda Aurpibul, وآخرون
منشور في: (2018)

Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in thai hiv-infected children aged two years or less
بواسطة: Thanyawee Puthanakit, وآخرون
منشور في: (2018)

Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in thai hiv-infected children aged two years or less
بواسطة: Thanyawee Puthanakit, وآخرون
منشور في: (2018)

Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral Therapy
بواسطة: Podjanee Jittamala, وآخرون
منشور في: (2018)

Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral Therapy
بواسطة: Podjanee Jittamala, وآخرون
منشور في: (2018)

Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
بواسطة: Aurpibul L., وآخرون
منشور في: (2014)

Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in thai hiv-infected children aged two years or less
بواسطة: Puthanakit T., وآخرون
منشور في: (2014)

Recovery From Lipodystrophy in HIV-infected Children After Substitution of Stavudine With Zidovudine in a Non-nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy
بواسطة: Aurpibul L., وآخرون
منشور في: (2014)

Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral Therapy
بواسطة: Jittamala P., وآخرون
منشور في: (2014)

Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy
بواسطة: Thanyawee Puthanakit, وآخرون
منشور في: (2018)

Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy
بواسطة: Thanyawee Puthanakit, وآخرون
منشور في: (2018)

Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand
بواسطة: B. Lee, وآخرون
منشور في: (2018)

Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand
بواسطة: B. Lee, وآخرون
منشور في: (2018)

Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand
بواسطة: Lee B., وآخرون
منشور في: (2014)

Multi-drug resistant HIV-1 reverse transcriptase genotype in children treated with dual nucleoside reverse transcriptase inhibitors (NRTIs)
بواسطة: Chulapan Engchanil, وآخرون
منشور في: (2018)

Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy
بواسطة: Mongkol Lao-araya, وآخرون
منشور في: (2018)

Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia
بواسطة: David C. Boettiger, وآخرون
منشور في: (2018)

Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia
بواسطة: Boettiger D., وآخرون
منشور في: (2017)

HIV-1 Drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
بواسطة: Somnuek Sungkanuparph, وآخرون
منشور في: (2018)

HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
بواسطة: Puthanakit T., وآخرون
منشور في: (2014)

HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
بواسطة: T. Puthanakit, وآخرون
منشور في: (2018)

HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
بواسطة: Puthanakit T., وآخرون
منشور في: (2014)

HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
بواسطة: T. Puthanakit, وآخرون
منشور في: (2018)

Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy
بواسطة: Linda Aurpibul, وآخرون
منشور في: (2018)

Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy
بواسطة: Linda Aurpibul, وآخرون
منشور في: (2018)

Measles outbreak in an orphanage: HIV-Infected children on antiretroviral therapy are still at risk
بواسطة: Linda Aurpibul, وآخرون
منشور في: (2018)

Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors
بواسطة: Sunee Sirivichayakul, وآخرون
منشور في: (2018)

Rapid CD4 decline after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy in a resource-limited setting
بواسطة: Somnuek Sungkanuparph, وآخرون
منشور في: (2018)

Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy
بواسطة: Thanyawee Puthanakit, وآخرون
منشور في: (2018)

Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy
بواسطة: Thanyawee Puthanakit, وآخرون
منشور في: (2018)

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out stavudine
بواسطة: Michele W. Tang, وآخرون
منشور في: (2018)

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out stavudine
بواسطة: Michele W. Tang, وآخرون
منشور في: (2018)

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out stavudine
بواسطة: Tang M.W., وآخرون
منشور في: (2014)

HIV-1 genotype after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and virological response after resumption of the same regimen
بواسطة: Somnuek Sungkanuparph, وآخرون
منشور في: (2018)

Effects of Zidovudine, nucleoside reverse transcriptase inhibitor, on the development of Danio rerio (Zebrafish) embryos
بواسطة: Nunag, Lincoln Chua
منشور في: (2013)

Antibody response to hepatitis B re-vaccination in HIV-infected children with immune recovery on highly active antiretroviral therapy
بواسطة: Mongkol Lao-araya, وآخرون
منشور في: (2018)

Molecular Docking Study of Phthalimide Derivatives as Non-nucleoside HIV-1 Reverse Transcriptase Inhibitor
بواسطة: Pimonluck Sittikornpaiboon, وآخرون
منشور في: (2019)